219 related articles for article (PubMed ID: 18604170)
1. Melanomagenesis: overcoming the barrier of melanocyte senescence.
Ha L; Merlino G; Sviderskaya EV
Cell Cycle; 2008 Jul; 7(13):1944-8. PubMed ID: 18604170
[TBL] [Abstract][Full Text] [Related]
2. Cellular senescence in naevi and immortalisation in melanoma: a role for p16?
Gray-Schopfer VC; Cheong SC; Chong H; Chow J; Moss T; Abdel-Malek ZA; Marais R; Wynford-Thomas D; Bennett DC
Br J Cancer; 2006 Aug; 95(4):496-505. PubMed ID: 16880792
[TBL] [Abstract][Full Text] [Related]
3. p16/cyclin-dependent kinase inhibitor 2A deficiency in human melanocyte senescence, apoptosis, and immortalization: possible implications for melanoma progression.
Sviderskaya EV; Gray-Schopfer VC; Hill SP; Smit NP; Evans-Whipp TJ; Bond J; Hill L; Bataille V; Peters G; Kipling D; Wynford-Thomas D; Bennett DC
J Natl Cancer Inst; 2003 May; 95(10):723-32. PubMed ID: 12759390
[TBL] [Abstract][Full Text] [Related]
4. Abrogation of BRAFV600E-induced senescence by PI3K pathway activation contributes to melanomagenesis.
Vredeveld LC; Possik PA; Smit MA; Meissl K; Michaloglou C; Horlings HM; Ajouaou A; Kortman PC; Dankort D; McMahon M; Mooi WJ; Peeper DS
Genes Dev; 2012 May; 26(10):1055-69. PubMed ID: 22549727
[TBL] [Abstract][Full Text] [Related]
5. Melanocytic nevus-like hyperplasia and melanoma in transgenic BRAFV600E mice.
Goel VK; Ibrahim N; Jiang G; Singhal M; Fee S; Flotte T; Westmoreland S; Haluska FS; Hinds PW; Haluska FG
Oncogene; 2009 Jun; 28(23):2289-98. PubMed ID: 19398955
[TBL] [Abstract][Full Text] [Related]
6. Activation of a cAMP pathway and induction of melanogenesis correlate with association of p16(INK4) and p27(KIP1) to CDKs, loss of E2F-binding activity, and premature senescence of human melanocytes.
Haddad MM; Xu W; Schwahn DJ; Liao F; Medrano EE
Exp Cell Res; 1999 Dec; 253(2):561-72. PubMed ID: 10585280
[TBL] [Abstract][Full Text] [Related]
7. Molecular regulation of melanocyte senescence.
Bennett DC; Medrano EE
Pigment Cell Res; 2002 Aug; 15(4):242-50. PubMed ID: 12100489
[TBL] [Abstract][Full Text] [Related]
8. Melanin accumulation accelerates melanocyte senescence by a mechanism involving p16INK4a/CDK4/pRB and E2F1.
Bandyopadhyay D; Medrano EE
Ann N Y Acad Sci; 2000 Jun; 908():71-84. PubMed ID: 10911949
[TBL] [Abstract][Full Text] [Related]
9. The relative contributions of the p53 and pRb pathways in oncogene-induced melanocyte senescence.
Haferkamp S; Tran SL; Becker TM; Scurr LL; Kefford RF; Rizos H
Aging (Albany NY); 2009 May; 1(6):542-56. PubMed ID: 20157537
[TBL] [Abstract][Full Text] [Related]
10. Genome-Wide Overexpression Screen Identifies Genes Able to Bypass p16-Mediated Senescence in Melanoma.
Lee WJ; Škalamera D; Dahmer-Heath M; Shakhbazov K; Ranall MV; Fox C; Lambie D; Stevenson AJ; Yaswen P; Gonda TJ; Gabrielli B
SLAS Discov; 2017 Mar; 22(3):298-308. PubMed ID: 27872202
[TBL] [Abstract][Full Text] [Related]
11. p15 Expression Differentiates Nevus from Melanoma.
Taylor LA; O'Day C; Dentchev T; Hood K; Chu EY; Ridky TW; Seykora JT
Am J Pathol; 2016 Dec; 186(12):3094-3099. PubMed ID: 27855847
[TBL] [Abstract][Full Text] [Related]
12. C-MYC overexpression is required for continuous suppression of oncogene-induced senescence in melanoma cells.
Zhuang D; Mannava S; Grachtchouk V; Tang WH; Patil S; Wawrzyniak JA; Berman AE; Giordano TJ; Prochownik EV; Soengas MS; Nikiforov MA
Oncogene; 2008 Nov; 27(52):6623-34. PubMed ID: 18679422
[TBL] [Abstract][Full Text] [Related]
13. Activation of forkhead box O transcription factors by oncogenic BRAF promotes p21cip1-dependent senescence.
de Keizer PL; Packer LM; Szypowska AA; Riedl-Polderman PE; van den Broek NJ; de Bruin A; Dansen TB; Marais R; Brenkman AB; Burgering BM
Cancer Res; 2010 Nov; 70(21):8526-36. PubMed ID: 20959475
[TBL] [Abstract][Full Text] [Related]
14. p53 prevents progression of nevi to melanoma predominantly through cell cycle regulation.
Terzian T; Torchia EC; Dai D; Robinson SE; Murao K; Stiegmann RA; Gonzalez V; Boyle GM; Powell MB; Pollock PM; Lozano G; Robinson WA; Roop DR; Box NF
Pigment Cell Melanoma Res; 2010 Dec; 23(6):781-94. PubMed ID: 20849464
[TBL] [Abstract][Full Text] [Related]
15. Senescence evasion in melanoma progression: uncoupling of DNA-damage signaling from p53 activation and p21 expression.
Mackenzie Ross AD; Cook MG; Chong H; Hossain M; Pandha HS; Bennett DC
Pigment Cell Melanoma Res; 2013 Mar; 26(2):226-35. PubMed ID: 23253087
[TBL] [Abstract][Full Text] [Related]
16. Human melanocyte senescence and melanoma susceptibility genes.
Bennett DC
Oncogene; 2003 May; 22(20):3063-9. PubMed ID: 12789281
[TBL] [Abstract][Full Text] [Related]
17. Genetics of melanoma progression: the rise and fall of cell senescence.
Bennett DC
Pigment Cell Melanoma Res; 2016 Mar; 29(2):122-40. PubMed ID: 26386262
[TBL] [Abstract][Full Text] [Related]
18. E2F1-dependent oncogenic addiction of melanoma cells to MDM2.
Verhaegen M; Checinska A; Riblett MB; Wang S; Soengas MS
Oncogene; 2012 Feb; 31(7):828-41. PubMed ID: 21743494
[TBL] [Abstract][Full Text] [Related]
19. Adenovirus-mediated overexpression of p15INK4B inhibits human glioma cell growth, induces replicative senescence, and inhibits telomerase activity similarly to p16INK4A.
Fuxe J; Akusjärvi G; Goike HM; Roos G; Collins VP; Pettersson RF
Cell Growth Differ; 2000 Jul; 11(7):373-84. PubMed ID: 10939591
[TBL] [Abstract][Full Text] [Related]
20. Oncogenic Braf induces melanocyte senescence and melanoma in mice.
Dhomen N; Reis-Filho JS; da Rocha Dias S; Hayward R; Savage K; Delmas V; Larue L; Pritchard C; Marais R
Cancer Cell; 2009 Apr; 15(4):294-303. PubMed ID: 19345328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]